与胃癌相关血清生物标志物研究进展
Advances in Serum Biomarkers Related to Gastric Cancer
DOI: 10.12677/ACM.2022.124495, PDF,   
作者: 任芳芳：青海大学研究生院，青海 西宁；张 翔：青海大学附属医院检验科，青海 西宁
关键词: 胃癌；筛选；肿瘤标志物；分子生物；Gastric Cancer； Screening； Tumor Markers； Molecular Biology
摘要: 胃癌(gastric carcinoma, GC)是一种普遍但异构疾病排名第五的最常见癌症之一，流行于全球，一直是世界上发病率、死亡率较高的常见肿瘤之一。被认为是最致命的胃肠道癌症。在全球范围内极大影响现代人健康。胃癌是复杂的异质性肿瘤，具有生物学和遗传学多样性。通过传统的手术和化学放射疗法虽然能改善早期胃癌患者的预后，然而一旦疾病传播到远处器官，由于治疗手段的局限性，导致临床结果不佳，因此鉴定新型标志物对于延长患者生存期尤为重要，随着分子标志物鉴定技术的研究进展和生物信息学以及功能基因组学的日益普及和增加，可用的潜在治疗方案也在增加。生物标志物有许多潜在的临床应用，包括筛选、评估风险、确定预后、监测复发和预测治疗。本文综述了近年来胃癌特异性生物标志物研究进展。
Abstract: Gastric cancer (GC) is one of the fifth most common cancers. It is prevalent worldwide and has been one of the common tumors with high incidence of morbidity and mortality in the world. It’s considered the deadliest gastrointestinal cancer. It greatly affects modern health around the world. Gastric cancer is a complex heterogeneous tumor with biological and genetic diversity. Although traditional surgery and chemoradiotherapy can improve the prognosis of patients with early gastric cancer, once the disease spreads to distant organs, due to the limitations of treatment methods, the clinical results are not good. Therefore, identification of novel markers is particularly important to prolong the survival of patients. With the development of molecular marker identification techniques and the increasing popularity and availability of bioinformatics and functional genomics, the potential therapeutic options available are also increasing. Biomarkers have many potential clinical applications, including screening, assessing risk, determining prognosis, monitoring relapse, and predicting treatment. This paper reviews the recent advances in the study of specific biomarkers for gastric cancer.
文章引用：任芳芳, 张翔. 与胃癌相关血清生物标志物研究进展[J]. 临床医学进展, 2022, 12(4): 3421-3428. https://doi.org/10.12677/ACM.2022.124495

参考文献

[1] Smyth, E.C., Nilsson, M., Grabsch, H.I., van Grieken, N.C. and Lordick, F. (2020) Gastric Cancer. The Lancet, 396, 635-648. [Google Scholar] [CrossRef] 
[2] Bray, F., Ferlay, J., Soerjomataram, I., Siegel, R.L., Torre, L.A. and Jemal, A. (2018) Global Cancer Statistics 2018: GLOBOCAN Estimates of Incidence and Mortality Worldwide for 36 Cancers in 185 Countries. CA: A Cancer Journal for Clinicians, 68, 394-424. [Google Scholar] [CrossRef] [PubMed]
[3] Bornschein, J., Leja, M., Kupcinskas, J., Link, A., Weaver, J., Rugge, M. and Malfertheiner, P. (2014) Molecular Diagnostics in Gastric Cancer. Frontiers in Bioscience-Landmark, 19, 312-338. [Google Scholar] [CrossRef] [PubMed]
[4] Shimada, H., Noie, T., Ohashi, M., Oba, K. and Takahashi, Y. (2014) Clinical Significance of Serum Tumor Markers for Gastric Cancer: A Systematic Review of Literature by the Task Force of the Japanese Gastric Cancer Association. Gastric Cancer, 17, 26-33. [Google Scholar] [CrossRef] [PubMed]
[5] Amin, B.D. and Hoda, S.A. (2012) Minimal Metastic Disease in Sentinal Lymphnodes in Breast Carcinoma: Some Modest Proposalsto Refine Criteria for “Isolate Tumor Cells”. Ad-vances in Anatomic Pathology, 13, 185-189. [Google Scholar] [CrossRef] [PubMed]
[6] Kogo, R., Mimori, K., Tanaka, F., et al. (2011) Clinical Significance of miR-146a in Gastric Cancer Cases. Clinical Cancer Research, 17, 4277-4284. [Google Scholar] [CrossRef] 
[7] Xuan, W., Yu, H., Zhang, X. and Song, D. (2019) Cross-talk between the lncRNA UCA1 and MicroRNAs in Cancer. FEBS Letters, 593, 1901-1914. [Google Scholar] [CrossRef] [PubMed]
[8] Ghafouri-Fard, S. and Taheri, M. (2019) UCA1 Long Non-Coding RNA: An Update on Its Roles in Malignant Behavior of Cancers. Biomedicine & Pharmacotherapy, 120, Article ID: 109459. [Google Scholar] [CrossRef] [PubMed]
[9] Yao, F., Wang, Q. and Wu, Q. (2019) The Prognostic Value and Mechanisms of lncRNA UCA1 in Human Cancer. Cancer Management and Research, 14, 7685-7696. [Google Scholar] [CrossRef] 
[10] Bae, S., Brumbaugh, J. and Bonavida, B. (2018) Exosomes Derived from Cancerous and Non-Cancerous Cells Regulate the Antitumor Response in the Tumor Microenvironment. Genes & Cancer, 9, 87-100. [Google Scholar] [CrossRef] [PubMed]
[11] Thomson, D.W. and Dinger, M.E. (2016) Endogenous MicroRNA Sponges: Evidence and Controversy. Nature Reviews Genetics, 17, 272-283. [Google Scholar] [CrossRef] [PubMed]
[12] Ghafouri-Fard, S., Shoorei, H., Anamag, F.T. and Taheri, M. (2020) The Role of Non-Coding RNAs in Controlling Cell Cycle Related Proteins in Cancer Cells. Frontiers in Oncology, 30, Article ID: 608975. [Google Scholar] [CrossRef] [PubMed]
[13] Cao, Y., Xiong, J.B., Zhang, G.Y., Liu, Y., Jie, Z.G. and Li, Z.R. (2020) Long Noncoding RNA UCA1 Regulates PRL-3 Expression by Sponging MicroRNA-495 to Promote the Pro-gression of Gastric Cancer. Molecular Therapy—Nucleic Acids, 19, 853-864. [Google Scholar] [CrossRef] [PubMed]
[14] Gong, P., Qiao, F., Wu, H., Cui, H., Li, Y., Zheng, Y., Zhou, M. and Fan, H. (2018) LncRNA UCA1 Promotes Tumor Metastasis by Inducing miR-203/ZEB2 Axis in Gastric Cancer. Cell Death & Disease, 9, Article No. 1158. [Google Scholar] [CrossRef] [PubMed]
[15] Lee, B., Hutchinson, R., Wong, H. L., Tie, J., Putoczki, T., Tran, B., et al. (2018) Emerging Biomarkers for Immunomodulatory Cancer Treatment of Upper Gastrointestinal, Pancreatic and Hepatic Cancers. Seminars in Cancer Biology, 52, 241-252. [Google Scholar] [CrossRef] [PubMed]
[16] Bentwich, I., Avniel, A., Karov, Y., et al. (2005) Identifi-cation of Hundreds of Conserved and Nonconserved Human MicroRNAs. Nature Genetics, 37, 766-770. [Google Scholar] [CrossRef] [PubMed]
[17] Bijnsdorp, I.V., Hodzic, J., Lagerweij, T., et al. (2016) miR-129-3p Controls Centrosome Number in Metastatic Prostate Cancer Cells by Repressing CP110. Oncotarget, 7, 16676-16687. [Google Scholar] [CrossRef] [PubMed]
[18] Link, A., Kupcinskas, J., Wex, T. and Malfertheiner, P. (2012) Macro-Role of MicroRNA in Gastric Cancer. Digestive Diseases, 30, 255-267. [Google Scholar] [CrossRef] [PubMed]
[19] Link, A. and Goel, A. (2013) MicroRNA in Gastrointestinal Cancer: A Step Closer to Reality. Advances in Clinical Chemistry, 62, 221-268. [Google Scholar] [CrossRef] 
[20] Lujambio, A. and Lowe, S.W. (2012) The Microcosmos of Cancer. Nature, 482, 347-355. [Google Scholar] [CrossRef] [PubMed]
[21] McLean, M.H. and El-Omar, E.M. (2014) Genetics of Gastric Cancer. Nature Reviews Gastroenterology & Hepatology, 11, 664-674. [Google Scholar] [CrossRef] [PubMed]
[22] Link, A., Schirrmeister, W., Langner, C., Varbanova, M., Bornschein, J., Wex, T. and Malfertheiner, P. (2015) Differential Expression of MicroRNAs in Preneoplastic Gastric Mucosa. Scientific Reports, 5, Article No. 8270. [Google Scholar] [CrossRef] [PubMed]
[23] Weber, J.A., Baxter, D.H., Zhang, S., Huang, D.Y., Huang, K.H., Lee, M.J., Galas, D.J. and Wang, K. (2010) The MicroRNA Spectrum in 12 Body Fluids. Clin Chem, 56, 1733-1741. [Google Scholar] [CrossRef] [PubMed]
[24] Sousa, J.F., Nam, K.T., Petersen, C.P., Lee, H.J., Yang, H.K., Kim, W.H. and Goldenring, J.R. (2016) miR-30-HNF4γ and miR-194-NR2F2 Regulatory Networks Contribute to the Upregulation of Metaplasia Markers in the Stomach. Gut, 65, 914-924. [Google Scholar] [CrossRef] [PubMed]
[25] Mishra, P.J. and Bertino, J.R. (2009) MicroRNA Polymorphisms: The Future of Pharmacogenomics, Molecular Epidemiology and Individualized Medicine. Pharmacogenomics, 10, 399-416. [Google Scholar] [CrossRef] [PubMed]
[26] Liu, C., Rennie, W.A., Carmack, C.S., Kanoria, S., Cheng, J., Lu, J. and Ding, Y. (2014) Effects of Genetic Variations on MicroRNA: Target Interactions. Nucleic Acids Research, 42, 9543-9552. [Google Scholar] [CrossRef] [PubMed]
[27] Kupcinskas, J., Bruzaite, I., Juzenas, S., Gyvyte, U., Jonaitis, L., Kiudelis, G., Skieceviciene, J., Leja, M., Pauzas, H., Tamelis, A., Pavalkis, D. and Kupcinskas, L. (2014) Lack of Association between miR-27a, miR-146a, miR-196a-2, miR-492 and miR-608 Gene Polymorphisms and Colorectal Cancer. Scientific Reports, 4, Article No. 5993. [Google Scholar] [CrossRef] [PubMed]
[28] Kupcinskas, J., Wex, T., Link, A., Leja, M., Bruzaite, I., Steponaitiene, R., Juzenas, S., Gyvyte, U., Ivanauskas, A., Ancans, G., Petrenkiene, V., Skieceviciene, J., Kupcinskas, L. and Malfertheiner, P. (2014) Gene Polymorphisms of MicroRNAs in Helicobacter pylori-Induced High Risk Atrophic Gastritis and Gastric Cancer. PLoS ONE, 9, e87467. [Google Scholar] [CrossRef] [PubMed]
[29] Fu, B., Song, P., Lu, M., Wang, B. and Zhao, Q. (2014) The Association between miR-146a Gene rs2910164 Polymorphism and Gastric Cancer Risk: A Meta-Analysis. Biomedicine & Pharmacotherapy, 68, 923-928. [Google Scholar] [CrossRef] [PubMed]
[30] Liu, S., Dong, H., Dai, H., Liu, D. and Wang, Z. (2018) MicroRNA-216b Regulated Proliferation and Invasion of Non-Small Cell Lung Cancer by Targeting SOX9. Oncology Letters, 15, 10077-10083. [Google Scholar] [CrossRef] [PubMed]
[31] Wang, W., Guo, Z., Yu, H. and Fan, L. (2019) Mir-216b Inhibits Os-teosarcoma Cell Proliferation, Migration, and Invasion by Targeting Forkhead Box M1. Journal of Cellular Biochemistry, 120, 5435-5443. [Google Scholar] [CrossRef] [PubMed]
[32] Shao, Q., Zhang, P., Ma, Y., Lu, Z., Meng, J., Li, H., et al. (2018) Microrna-139-5p Affects Cisplatin Sensitivity in Human Nasopharyngeal Carcinoma Cells by Regulating the Epitheli-al-to-Mesenchymal Transition. Gene, 652, 48-58. [Google Scholar] [CrossRef] [PubMed]
[33] Pfeifer, G.P. (2018) Defining Driver DNA Methylation Changes in Human Cancer. International Journal of Molecular Sciences, 19, Article No. 1166.
[34] Eyvazi, S., Khamaneh, A.M., Tarhriz, V., Bandehpour, M., Hejazi, M.S., Sadat, A.T.E. and Sepehri, B. (2019) CpG Islands Methylation Analysis of CDH11, EphA5, and HS3ST2 Genes in Gastric Adenocarcinoma Patients. Journal of Gastrointestinal Cancer, 51, 579-583. [Google Scholar] [CrossRef] [PubMed]
[35] Prabhu, A., Sarcar, B., Kahali, S., et al. (2014) Cysteine Catabolism: A Novel Metabolic Pathway Contributing to Glioblastoma Growth. Cancer Research, 74, 787-796. [Google Scholar] [CrossRef] 
[36] Miki, K. and Urita, Y. (2007) Using Serum Pepsinogens Wisely in a Clinical Practice. Journal of Digestive Diseases, 8, 8-14. [Google Scholar] [CrossRef] [PubMed]
[37] Pimanov, S.I., Makarenko, E.V., Voropaeva, A.V., Matveenko, M.E. and Voropaev, E.V. (2008) Helicobacter pylori Eradication Improves Gastric Histology and Decreases Serum Gastrin, Pepsinogen I and Pepsinogen II Levels in Patients with Duodenal Ulcer. Journal of Gastroenterology and Hepatology, 23, 1666-1671. [Google Scholar] [CrossRef] [PubMed]
[38] Nam, S.Y., Jeon, S.W., Lee, H.S., Kwon, Y.H., Park, H. and Choi, J.W. (2017) Long-Term Follow-Up of Pepsinogen I/II Ratio after Eradication of Helicobacter pylori in Pa-tients Who Underwent Endoscopic Mucosal Resection for Gastric Cancer. Digestive and Liver Disease, 49, 500-506. [Google Scholar] [CrossRef] [PubMed]
[39] Cho, J.H., Jeon, S.R., Kim, H.G., Jin, S.Y. and Park, S. (2017) The Serum Pepsinogen Levels for Risk Assessment of Gastric Neoplasms: New Proposal from a Case-Control Study in Korea. Medicine, 96, e7603. [Google Scholar] [CrossRef] 
[40] Siegel, R.L., Miller, K.D. and Jemal, A. (2018) Cancer Statistics, 2018. CA: A Cancer Journal for Clinicians, 68, 7-30. [Google Scholar] [CrossRef] [PubMed]
[41] Malfertheiner, P., Megraud, F., O’Morain, C.A., Gisbert, J.P., Kuipers, E.J., Axon, A.T., Bazzoli, F., Gasbarrini, A., Atherton, J., Graham, D.Y., Hunt, R., Moayyedi, P., Rokkas, T., Rugge, M., Selgrad, M., Suerbaum, S., Sugano, K. and El-Omar, E.M. (European Helicobacter and Microbiota Study Group and Consensus Panel) (2017) Management of Helicobacter pylori Infection: The Maastricht V/Florence Consensus Report. Gut, 66, 6-30. [Google Scholar] [CrossRef] [PubMed]
[42] Li, W., et al. (2014) Role of Exosomal Proteins in Cancer Di-agnosis. Gastric Cancer, 17, 26-33.
[43] Ruivo, C.F., et al. (2017) The Biology of Cancer Exosomes: Insights and New Perspectives. Cancer Research, 77, 6480-6488. [Google Scholar] [CrossRef] 
[44] Zhang, H., Deng, T., Liu, R., et al. (2017) Exosome-Delivered EGFR Regulates Liver Microenvironment to Promote Gastric Cancer Liver Metastasis. Nature Communications, 8, Article ID: 15016. [Google Scholar] [CrossRef] [PubMed]
[45] Zhou, L., et al. (2017) The Biology, Function and Clinical Implications of Exosomes in Lung Cancer. Cancer Letters, 407, 84-92. [Google Scholar] [CrossRef] [PubMed]

为你推荐